BMJ Group Logo

BMJ finds inaccuracies in key studies for AstraZeneca’s blockbuster heart drug ticagrelor

Investigation finds evidence of serious misreporting, raising fresh doubts over the approval and decade long use of ticagrelor In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval. For more than a decade, ticagrelor ...

2025-06-20T09:46:36+01:0020 June 2025|Press release, The BMJ|

Intermittent fasting comparable to traditional diets for weight loss

May also offer other health benefits, but longer trials are needed to confirm this Intermittent fasting diets appear to have similar benefits to traditional calorie-restricted diets for weight loss, suggests an analysis of trial evidence published by The BMJ today. Alternate day fasting also demonstrates greater benefits compared with both calorie restriction ...

2025-06-19T09:39:25+01:0019 June 2025|Press release, The BMJ|

Doctors raise concern over rise in recreational ketamine use

More individuals are seeking treatment for ketamine addiction Greater awareness, research, and treatments are needed The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in The BMJ today. Irene Guerrini at South London & Maudsley NHS Foundation Trust and colleagues warn that ...

2025-06-12T10:38:40+01:0012 June 2025|Press release, The BMJ|

Humanising health: conflict, equity, and resilience

Podcasts Analysis Opinion Recordings Meeting report World Health Innovation Summit (WISH) 2024 BMJ Group partnered with the Qatar Foundation to support the World Health Innovation Summit (WISH) 2024, a leading global health event that brings together policymakers, researchers, and healthcare professionals. ...

Over half of doctors surveyed would consider assisted dying if they had advanced cancer or Alzheimer’s disease

And they mostly prefer symptom relief at end of life rather than prolongation of life But preferences vary according to their jurisdiction’s legislation on assisted dying When it comes to advanced cancer or Alzheimer’s disease, over half of doctors would consider assisted dying for themselves, but preferences seem to vary ...

2025-06-11T10:23:56+01:0011 June 2025|Journal of Medical Ethics, Press release|
Go to Top